Name | Number of supported studies | Average coverage | |
---|---|---|---|
ciliated cell | 5 studies | 23% ± 8% | |
glutamatergic neuron | 4 studies | 37% ± 14% | |
oligodendrocyte | 4 studies | 20% ± 2% | |
GABAergic neuron | 3 studies | 35% ± 8% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 5 studies | 27% ± 8% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 97% | 1186.59 | 2565 / 2642 | 80% | 2.68 | 564 / 705 |
esophagus | 98% | 904.40 | 1415 / 1445 | 75% | 3.87 | 138 / 183 |
prostate | 94% | 461.44 | 231 / 245 | 75% | 2.48 | 379 / 502 |
lung | 98% | 1018.84 | 568 / 578 | 67% | 3.16 | 779 / 1155 |
breast | 79% | 356.34 | 364 / 459 | 72% | 2.24 | 809 / 1118 |
kidney | 99% | 640.08 | 88 / 89 | 49% | 1.30 | 445 / 901 |
stomach | 97% | 590.44 | 348 / 359 | 44% | 1.40 | 126 / 286 |
pancreas | 80% | 333.84 | 264 / 328 | 58% | 1.48 | 104 / 178 |
bladder | 100% | 459.48 | 21 / 21 | 39% | 1.27 | 195 / 504 |
ovary | 81% | 271.19 | 146 / 180 | 56% | 1.89 | 241 / 430 |
intestine | 96% | 640.85 | 927 / 966 | 40% | 1.24 | 213 / 527 |
liver | 93% | 492.88 | 210 / 226 | 43% | 1.18 | 175 / 406 |
uterus | 76% | 338.69 | 130 / 170 | 49% | 1.78 | 225 / 459 |
thymus | 95% | 553.90 | 621 / 653 | 18% | 0.43 | 108 / 605 |
spleen | 99% | 647.07 | 239 / 241 | 0% | 0 | 0 / 0 |
heart | 97% | 949.25 | 832 / 861 | 0% | 0 | 0 / 0 |
adrenal gland | 29% | 73.84 | 75 / 258 | 58% | 1.86 | 134 / 230 |
skin | 66% | 377.91 | 1202 / 1809 | 15% | 0.37 | 73 / 472 |
blood vessel | 69% | 235.22 | 926 / 1335 | 0% | 0 | 0 / 0 |
adipose | 68% | 234.83 | 814 / 1204 | 0% | 0 | 0 / 0 |
muscle | 60% | 195.56 | 485 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 42% | 1.11 | 19 / 45 |
eye | 0% | 0 | 0 / 0 | 26% | 0.53 | 21 / 80 |
lymph node | 0% | 0 | 0 / 0 | 21% | 0.91 | 6 / 29 |
peripheral blood | 11% | 24.82 | 104 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0018230 | Biological process | peptidyl-L-cysteine S-palmitoylation |
GO_0140374 | Biological process | antiviral innate immune response |
GO_0006612 | Biological process | protein targeting to membrane |
GO_0002230 | Biological process | positive regulation of defense response to virus by host |
GO_0010008 | Cellular component | endosome membrane |
GO_0000139 | Cellular component | Golgi membrane |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0019706 | Molecular function | protein-cysteine S-palmitoyltransferase activity |
GO_0035591 | Molecular function | signaling adaptor activity |
GO_0005515 | Molecular function | protein binding |
Gene name | ZDHHC11 |
Protein name | Zinc finger DHHC-type containing 11 Palmitoyltransferase (EC 2.3.1.225) Palmitoyltransferase ZDHHC11 (EC 2.3.1.225) (Zinc finger DHHC domain-containing protein 11) (DHHC-11) (Zinc finger protein 399) |
Synonyms | ZNF399 |
Description | FUNCTION: Endoplasmic reticulum-localized palmitoyltransferase that could catalyze the addition of palmitate onto various protein substrates and be involved in a variety of cellular processes (By similarity). Has a palmitoyltransferase activity toward NCDN and regulates NCDN association with endosome membranes through this palmitoylation (By similarity). May play a role in cell proliferation . .; FUNCTION: Has also a palmitoyltransferase activity-independent function in DNA virus-triggered and CGAS-mediated innate immune response . Functions as an adapter that recruits IRF3 to STING1 to promote the activation of that key transcriptional regulator of type I interferon (IFN)-dependent immune response . . |
Accessions | D6RE92 ENST00000507800.1 ENST00000511193.1 H0Y9D0 ENST00000685990.1 A0A8I5KQG6 Q9H8X9 ENST00000283441.13 [Q9H8X9-1] ENST00000511539.1 [Q9H8X9-2] |